http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 14 Aug 2026 16:15:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SYNLOGIC%2C+INC.++++++++++++For%3A+Jul+27++Filed+by%3A+NEA+14+GP%2C+LTD/26930555.html si-local-file:///var/storage/secattach/20260814/26930555.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SYNLOGIC%2C+INC.++++++++++++For%3A+Jul+27++Filed+by%3A+NEA+14+GP%2C+LTD/26930555.html Fri, 14 Aug 2026 16:15:00 -0400 O.25511864 SYBX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SYNLOGIC%2C+INC.++++++++++++For%3A+Jul+27++Filed+by%3A+NEA+14+GP%2C+LTD/26930555.html si-local-file:///var/storage/secattach/20260814/26930555.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SYNLOGIC%2C+INC.++++++++++++For%3A+Jul+27++Filed+by%3A+NEA+14+GP%2C+LTD/26930555.html Fri, 14 Aug 2026 16:15:00 -0400 O.25511864 SYBX http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++SYNLOGIC%2C+INC.++++++++++++For%3A+Jun+30/26906362.html si-local-file:///var/storage/secattach/20260811/26906362.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++SYNLOGIC%2C+INC.++++++++++++For%3A+Jun+30/26906362.html Tue, 11 Aug 2026 16:31:00 -0400 O.25511864 SYBX http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++SYNLOGIC%2C+INC.++++++++++++For%3A+Jun+30/26906362.html si-local-file:///var/storage/secattach/20260811/26906362.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++SYNLOGIC%2C+INC.++++++++++++For%3A+Jun+30/26906362.html Tue, 11 Aug 2026 16:31:00 -0400 O.25511864 SYBX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++SYNLOGIC%2C+INC.+++++++++++++++++++++++++Filed+by%3A+New+Enterprise+Associates+14%2C+L.P./26836846.html si-local-file:///var/storage/secattach/20260729/26836846.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++SYNLOGIC%2C+INC.+++++++++++++++++++++++++Filed+by%3A+New+Enterprise+Associates+14%2C+L.P./26836846.html Wed, 29 Jul 2026 19:40:00 -0400 O.25511864 SYBX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++SYNLOGIC%2C+INC.+++++++++++++++++++++++++Filed+by%3A+New+Enterprise+Associates+14%2C+L.P./26836846.html si-local-file:///var/storage/secattach/20260729/26836846.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++SYNLOGIC%2C+INC.+++++++++++++++++++++++++Filed+by%3A+New+Enterprise+Associates+14%2C+L.P./26836846.html Wed, 29 Jul 2026 19:40:00 -0400 O.25511864 SYBX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++SYNLOGIC%2C+INC.+++++++++++++++++++++++++Filed+by%3A+Funicular+Funds%2C+LP/26835377.html si-local-file:///var/storage/secattach/20260729/26835377.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++SYNLOGIC%2C+INC.+++++++++++++++++++++++++Filed+by%3A+Funicular+Funds%2C+LP/26835377.html Wed, 29 Jul 2026 16:19:00 -0400 O.25511864 SYBX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++SYNLOGIC%2C+INC.+++++++++++++++++++++++++Filed+by%3A+Funicular+Funds%2C+LP/26835377.html si-local-file:///var/storage/secattach/20260729/26835377.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++SYNLOGIC%2C+INC.+++++++++++++++++++++++++Filed+by%3A+Funicular+Funds%2C+LP/26835377.html Wed, 29 Jul 2026 16:19:00 -0400 O.25511864 SYBX http://www.streetinsider.com/SEC+Filings/Form++425++++++++SYNLOGIC%2C+INC.+++++++++++++++++++++++++Filed+by%3A+SYNLOGIC%2C+INC./26830586.html si-local-file:///var/storage/secattach/20260729/26830586.html http://www.streetinsider.com/SEC+Filings/Form++425++++++++SYNLOGIC%2C+INC.+++++++++++++++++++++++++Filed+by%3A+SYNLOGIC%2C+INC./26830586.html Wed, 29 Jul 2026 07:26:00 -0400 O.25511864 SYBX http://www.streetinsider.com/SEC+Filings/Form++425++++++++SYNLOGIC%2C+INC.+++++++++++++++++++++++++Filed+by%3A+SYNLOGIC%2C+INC./26830586.html si-local-file:///var/storage/secattach/20260729/26830586.html http://www.streetinsider.com/SEC+Filings/Form++425++++++++SYNLOGIC%2C+INC.+++++++++++++++++++++++++Filed+by%3A+SYNLOGIC%2C+INC./26830586.html Wed, 29 Jul 2026 07:26:00 -0400 O.25511864 SYBX http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++SYNLOGIC%2C+INC.++++++++++++For%3A+Jul+27/26830558.html si-local-file:///var/storage/secattach/20260729/26830558.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++SYNLOGIC%2C+INC.++++++++++++For%3A+Jul+27/26830558.html Wed, 29 Jul 2026 07:20:00 -0400 O.25511864 SYBX http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++SYNLOGIC%2C+INC.++++++++++++For%3A+Jul+27/26830558.html si-local-file:///var/storage/secattach/20260729/26830558.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++SYNLOGIC%2C+INC.++++++++++++For%3A+Jul+27/26830558.html Wed, 29 Jul 2026 07:20:00 -0400 O.25511864 SYBX http://www.streetinsider.com/Equity+Offerings/Synlogic+and+Caldera+Therapeutics+agree+to+all-stock+merger/26830320.html <p>Synlogic, Inc. (OTC: SYBX) and privately held Caldera Therapeutics, Inc. have entered into a definitive all-stock merger agreement, with the combined company planning to operate under the Caldera Therapeutics name and apply to list on the Nasdaq Capital Market under the ticker symbol "CALD."</p> <p>Under the merger terms, pre-merger Synlogic stockholders are expected to own approximately 2.3% of the combined company, pre-merger Caldera stockholders approximately 62.8%, and investors in a concurrent private placement approximately 34.9%.</p> <p>Caldera has secured commitments for a $278 million private placement from a syndicate of institutional investors and mutual funds, including Bain Capital Life Sciences, TCGX, Atlas Venture, http://www.streetinsider.com/Equity+Offerings/Synlogic+and+Caldera+Therapeutics+agree+to+all-stock+merger/26830320.html Wed, 29 Jul 2026 07:00:32 -0400 A.00157782 A.06812515 A.07414818 A.12626223 A.14185667 A.31205848 A.50100012 A.50200171 A.50216988 A.60001732 O.00048851 O.00163824 O.00478238 O.00812673 O.03227691 O.07579093 O.22066148 O.22801920 O.25511864 O.48188562 O.72995714 SYBX http://www.streetinsider.com/Equity+Offerings/Synlogic+and+Caldera+Therapeutics+agree+to+all-stock+merger/26830320.html <p>Synlogic, Inc. (OTC: SYBX) and privately held Caldera Therapeutics, Inc. have entered into a definitive all-stock merger agreement, with the combined company planning to operate under the Caldera Therapeutics name and apply to list on the Nasdaq Capital Market under the ticker symbol "CALD."</p> <p>Under the merger terms, pre-merger Synlogic stockholders are expected to own approximately 2.3% of the combined company, pre-merger Caldera stockholders approximately 62.8%, and investors in a concurrent private placement approximately 34.9%.</p> <p>Caldera has secured commitments for a $278 million private placement from a syndicate of institutional investors and mutual funds, including Bain Capital Life Sciences, TCGX, Atlas Venture, http://www.streetinsider.com/Equity+Offerings/Synlogic+and+Caldera+Therapeutics+agree+to+all-stock+merger/26830320.html Wed, 29 Jul 2026 07:00:32 -0400 A.00157782 A.06812515 A.07414818 A.12626223 A.14185667 A.31205848 A.50100012 A.50200171 A.50216988 A.60001732 O.00048851 O.00163824 O.00478238 O.00812673 O.03227691 O.07579093 O.22066148 O.22801920 O.25511864 O.48188562 O.72995714 SYBX http://www.streetinsider.com/Equity+Offerings/Synlogic+and+Caldera+Therapeutics+agree+to+all-stock+merger/26830320.html <p>Synlogic, Inc. (OTC: SYBX) and privately held Caldera Therapeutics, Inc. have entered into a definitive all-stock merger agreement, with the combined company planning to operate under the Caldera Therapeutics name and apply to list on the Nasdaq Capital Market under the ticker symbol "CALD."</p> <p>Under the merger terms, pre-merger Synlogic stockholders are expected to own approximately 2.3% of the combined company, pre-merger Caldera stockholders approximately 62.8%, and investors in a concurrent private placement approximately 34.9%.</p> <p>Caldera has secured commitments for a $278 million private placement from a syndicate of institutional investors and mutual funds, including Bain Capital Life Sciences, TCGX, Atlas Venture, http://www.streetinsider.com/Equity+Offerings/Synlogic+and+Caldera+Therapeutics+agree+to+all-stock+merger/26830320.html Wed, 29 Jul 2026 07:00:32 -0400 A.00157782 A.06812515 A.07414818 A.12626223 A.14185667 A.31205848 A.50100012 A.50200171 A.50216988 A.60001732 O.00048851 O.00163824 O.00478238 O.00812673 O.03227691 O.07579093 O.22066148 O.22801920 O.25511864 O.48188562 O.72995714 SYBX http://www.streetinsider.com/Equity+Offerings/Synlogic+and+Caldera+Therapeutics+agree+to+all-stock+merger/26830320.html <p>Synlogic, Inc. (OTC: SYBX) and privately held Caldera Therapeutics, Inc. have entered into a definitive all-stock merger agreement, with the combined company planning to operate under the Caldera Therapeutics name and apply to list on the Nasdaq Capital Market under the ticker symbol "CALD."</p> <p>Under the merger terms, pre-merger Synlogic stockholders are expected to own approximately 2.3% of the combined company, pre-merger Caldera stockholders approximately 62.8%, and investors in a concurrent private placement approximately 34.9%.</p> <p>Caldera has secured commitments for a $278 million private placement from a syndicate of institutional investors and mutual funds, including Bain Capital Life Sciences, TCGX, Atlas Venture, http://www.streetinsider.com/Equity+Offerings/Synlogic+and+Caldera+Therapeutics+agree+to+all-stock+merger/26830320.html Wed, 29 Jul 2026 07:00:32 -0400 A.00157782 A.06812515 A.07414818 A.12626223 A.14185667 A.31205848 A.50100012 A.50200171 A.50216988 A.60001732 O.00048851 O.00163824 O.00478238 O.00812673 O.03227691 O.07579093 O.22066148 O.22801920 O.25511864 O.48188562 O.72995714 SYBX http://www.streetinsider.com/Equity+Offerings/Synlogic+and+Caldera+Therapeutics+agree+to+all-stock+merger/26830320.html <p>Synlogic, Inc. (OTC: SYBX) and privately held Caldera Therapeutics, Inc. have entered into a definitive all-stock merger agreement, with the combined company planning to operate under the Caldera Therapeutics name and apply to list on the Nasdaq Capital Market under the ticker symbol "CALD."</p> <p>Under the merger terms, pre-merger Synlogic stockholders are expected to own approximately 2.3% of the combined company, pre-merger Caldera stockholders approximately 62.8%, and investors in a concurrent private placement approximately 34.9%.</p> <p>Caldera has secured commitments for a $278 million private placement from a syndicate of institutional investors and mutual funds, including Bain Capital Life Sciences, TCGX, Atlas Venture, http://www.streetinsider.com/Equity+Offerings/Synlogic+and+Caldera+Therapeutics+agree+to+all-stock+merger/26830320.html Wed, 29 Jul 2026 07:00:32 -0400 A.00157782 A.06812515 A.07414818 A.12626223 A.14185667 A.31205848 A.50100012 A.50200171 A.50216988 A.60001732 O.00048851 O.00163824 O.00478238 O.00812673 O.03227691 O.07579093 O.22066148 O.22801920 O.25511864 O.48188562 O.72995714 SYBX http://www.streetinsider.com/Equity+Offerings/Synlogic+and+Caldera+Therapeutics+agree+to+all-stock+merger/26830320.html <p>Synlogic, Inc. (OTC: SYBX) and privately held Caldera Therapeutics, Inc. have entered into a definitive all-stock merger agreement, with the combined company planning to operate under the Caldera Therapeutics name and apply to list on the Nasdaq Capital Market under the ticker symbol "CALD."</p> <p>Under the merger terms, pre-merger Synlogic stockholders are expected to own approximately 2.3% of the combined company, pre-merger Caldera stockholders approximately 62.8%, and investors in a concurrent private placement approximately 34.9%.</p> <p>Caldera has secured commitments for a $278 million private placement from a syndicate of institutional investors and mutual funds, including Bain Capital Life Sciences, TCGX, Atlas Venture, http://www.streetinsider.com/Equity+Offerings/Synlogic+and+Caldera+Therapeutics+agree+to+all-stock+merger/26830320.html Wed, 29 Jul 2026 07:00:32 -0400 A.00157782 A.06812515 A.07414818 A.12626223 A.14185667 A.31205848 A.50100012 A.50200171 A.50216988 A.60001732 O.00048851 O.00163824 O.00478238 O.00812673 O.03227691 O.07579093 O.22066148 O.22801920 O.25511864 O.48188562 O.72995714 SYBX http://www.streetinsider.com/Equity+Offerings/Synlogic+and+Caldera+Therapeutics+agree+to+all-stock+merger/26830320.html <p>Synlogic, Inc. (OTC: SYBX) and privately held Caldera Therapeutics, Inc. have entered into a definitive all-stock merger agreement, with the combined company planning to operate under the Caldera Therapeutics name and apply to list on the Nasdaq Capital Market under the ticker symbol "CALD."</p> <p>Under the merger terms, pre-merger Synlogic stockholders are expected to own approximately 2.3% of the combined company, pre-merger Caldera stockholders approximately 62.8%, and investors in a concurrent private placement approximately 34.9%.</p> <p>Caldera has secured commitments for a $278 million private placement from a syndicate of institutional investors and mutual funds, including Bain Capital Life Sciences, TCGX, Atlas Venture, http://www.streetinsider.com/Equity+Offerings/Synlogic+and+Caldera+Therapeutics+agree+to+all-stock+merger/26830320.html Wed, 29 Jul 2026 07:00:32 -0400 A.00157782 A.06812515 A.07414818 A.12626223 A.14185667 A.31205848 A.50100012 A.50200171 A.50216988 A.60001732 O.00048851 O.00163824 O.00478238 O.00812673 O.03227691 O.07579093 O.22066148 O.22801920 O.25511864 O.48188562 O.72995714 SYBX http://www.streetinsider.com/Equity+Offerings/Synlogic+and+Caldera+Therapeutics+agree+to+all-stock+merger/26830320.html <p>Synlogic, Inc. (OTC: SYBX) and privately held Caldera Therapeutics, Inc. have entered into a definitive all-stock merger agreement, with the combined company planning to operate under the Caldera Therapeutics name and apply to list on the Nasdaq Capital Market under the ticker symbol "CALD."</p> <p>Under the merger terms, pre-merger Synlogic stockholders are expected to own approximately 2.3% of the combined company, pre-merger Caldera stockholders approximately 62.8%, and investors in a concurrent private placement approximately 34.9%.</p> <p>Caldera has secured commitments for a $278 million private placement from a syndicate of institutional investors and mutual funds, including Bain Capital Life Sciences, TCGX, Atlas Venture, http://www.streetinsider.com/Equity+Offerings/Synlogic+and+Caldera+Therapeutics+agree+to+all-stock+merger/26830320.html Wed, 29 Jul 2026 07:00:32 -0400 A.00157782 A.06812515 A.07414818 A.12626223 A.14185667 A.31205848 A.50100012 A.50200171 A.50216988 A.60001732 O.00048851 O.00163824 O.00478238 O.00812673 O.03227691 O.07579093 O.22066148 O.22801920 O.25511864 O.48188562 O.72995714 SYBX http://www.streetinsider.com/Equity+Offerings/Synlogic+and+Caldera+Therapeutics+agree+to+all-stock+merger/26830320.html <p>Synlogic, Inc. (OTC: SYBX) and privately held Caldera Therapeutics, Inc. have entered into a definitive all-stock merger agreement, with the combined company planning to operate under the Caldera Therapeutics name and apply to list on the Nasdaq Capital Market under the ticker symbol "CALD."</p> <p>Under the merger terms, pre-merger Synlogic stockholders are expected to own approximately 2.3% of the combined company, pre-merger Caldera stockholders approximately 62.8%, and investors in a concurrent private placement approximately 34.9%.</p> <p>Caldera has secured commitments for a $278 million private placement from a syndicate of institutional investors and mutual funds, including Bain Capital Life Sciences, TCGX, Atlas Venture, http://www.streetinsider.com/Equity+Offerings/Synlogic+and+Caldera+Therapeutics+agree+to+all-stock+merger/26830320.html Wed, 29 Jul 2026 07:00:32 -0400 A.00157782 A.06812515 A.07414818 A.12626223 A.14185667 A.31205848 A.50100012 A.50200171 A.50216988 A.60001732 O.00048851 O.00163824 O.00478238 O.00812673 O.03227691 O.07579093 O.22066148 O.22801920 O.25511864 O.48188562 O.72995714 SYBX http://www.streetinsider.com/Equity+Offerings/Synlogic+and+Caldera+Therapeutics+agree+to+all-stock+merger/26830320.html <p>Synlogic, Inc. (OTC: SYBX) and privately held Caldera Therapeutics, Inc. have entered into a definitive all-stock merger agreement, with the combined company planning to operate under the Caldera Therapeutics name and apply to list on the Nasdaq Capital Market under the ticker symbol "CALD."</p> <p>Under the merger terms, pre-merger Synlogic stockholders are expected to own approximately 2.3% of the combined company, pre-merger Caldera stockholders approximately 62.8%, and investors in a concurrent private placement approximately 34.9%.</p> <p>Caldera has secured commitments for a $278 million private placement from a syndicate of institutional investors and mutual funds, including Bain Capital Life Sciences, TCGX, Atlas Venture, http://www.streetinsider.com/Equity+Offerings/Synlogic+and+Caldera+Therapeutics+agree+to+all-stock+merger/26830320.html Wed, 29 Jul 2026 07:00:32 -0400 A.00157782 A.06812515 A.07414818 A.12626223 A.14185667 A.31205848 A.50100012 A.50200171 A.50216988 A.60001732 O.00048851 O.00163824 O.00478238 O.00812673 O.03227691 O.07579093 O.22066148 O.22801920 O.25511864 O.48188562 O.72995714 SYBX http://www.streetinsider.com/Equity+Offerings/Synlogic+and+Caldera+Therapeutics+agree+to+all-stock+merger/26830320.html <p>Synlogic, Inc. (OTC: SYBX) and privately held Caldera Therapeutics, Inc. have entered into a definitive all-stock merger agreement, with the combined company planning to operate under the Caldera Therapeutics name and apply to list on the Nasdaq Capital Market under the ticker symbol "CALD."</p> <p>Under the merger terms, pre-merger Synlogic stockholders are expected to own approximately 2.3% of the combined company, pre-merger Caldera stockholders approximately 62.8%, and investors in a concurrent private placement approximately 34.9%.</p> <p>Caldera has secured commitments for a $278 million private placement from a syndicate of institutional investors and mutual funds, including Bain Capital Life Sciences, TCGX, Atlas Venture, http://www.streetinsider.com/Equity+Offerings/Synlogic+and+Caldera+Therapeutics+agree+to+all-stock+merger/26830320.html Wed, 29 Jul 2026 07:00:32 -0400 A.00157782 A.06812515 A.07414818 A.12626223 A.14185667 A.31205848 A.50100012 A.50200171 A.50216988 A.60001732 O.00048851 O.00163824 O.00478238 O.00812673 O.03227691 O.07579093 O.22066148 O.22801920 O.25511864 O.48188562 O.72995714 SYBX http://www.streetinsider.com/Equity+Offerings/Synlogic+and+Caldera+Therapeutics+agree+to+all-stock+merger/26830320.html <p>Synlogic, Inc. (OTC: SYBX) and privately held Caldera Therapeutics, Inc. have entered into a definitive all-stock merger agreement, with the combined company planning to operate under the Caldera Therapeutics name and apply to list on the Nasdaq Capital Market under the ticker symbol "CALD."</p> <p>Under the merger terms, pre-merger Synlogic stockholders are expected to own approximately 2.3% of the combined company, pre-merger Caldera stockholders approximately 62.8%, and investors in a concurrent private placement approximately 34.9%.</p> <p>Caldera has secured commitments for a $278 million private placement from a syndicate of institutional investors and mutual funds, including Bain Capital Life Sciences, TCGX, Atlas Venture, http://www.streetinsider.com/Equity+Offerings/Synlogic+and+Caldera+Therapeutics+agree+to+all-stock+merger/26830320.html Wed, 29 Jul 2026 07:00:32 -0400 A.00157782 A.06812515 A.07414818 A.12626223 A.14185667 A.31205848 A.50100012 A.50200171 A.50216988 A.60001732 O.00048851 O.00163824 O.00478238 O.00812673 O.03227691 O.07579093 O.22066148 O.22801920 O.25511864 O.48188562 O.72995714 SYBX http://www.streetinsider.com/Equity+Offerings/Synlogic+and+Caldera+Therapeutics+agree+to+all-stock+merger/26830320.html <p>Synlogic, Inc. (OTC: SYBX) and privately held Caldera Therapeutics, Inc. have entered into a definitive all-stock merger agreement, with the combined company planning to operate under the Caldera Therapeutics name and apply to list on the Nasdaq Capital Market under the ticker symbol "CALD."</p> <p>Under the merger terms, pre-merger Synlogic stockholders are expected to own approximately 2.3% of the combined company, pre-merger Caldera stockholders approximately 62.8%, and investors in a concurrent private placement approximately 34.9%.</p> <p>Caldera has secured commitments for a $278 million private placement from a syndicate of institutional investors and mutual funds, including Bain Capital Life Sciences, TCGX, Atlas Venture, http://www.streetinsider.com/Equity+Offerings/Synlogic+and+Caldera+Therapeutics+agree+to+all-stock+merger/26830320.html Wed, 29 Jul 2026 07:00:32 -0400 A.00157782 A.06812515 A.07414818 A.12626223 A.14185667 A.31205848 A.50100012 A.50200171 A.50216988 A.60001732 O.00048851 O.00163824 O.00478238 O.00812673 O.03227691 O.07579093 O.22066148 O.22801920 O.25511864 O.48188562 O.72995714 SYBX